Health

High Uptake of RSVpreF and Nirsevimab Among Infants

TribeNews
By TribeNews 1 View Add a Comment
0 Min Read
High Uptake of RSVpreF and Nirsevimab Among Infants

TOPLINE: Nearly three fourths of infants born during the 2023-2024 respiratory syncytial virus (RSV) season received protection with either nirsevimab or exposure to maternal RSVpreF, with maternal RSVpreF exposure being higher among infants of older mothers, while nirsevimab was predominantly administered to infants of younger mothers…

Leave a Comment
Ads Blocker Image Powered by Code Help Pro

Ads Blocker Detected & This Is Prohibited!!!

We have detected that you are using extensions to block ads and you are also not using our official app. Your Account Have been Flagged and reported, pending de-activation & All your earning will be wiped out. Please turn off the software to continue

You cannot copy content of this app